Nicholas Boston
@Highvista Strategies Llc
Latest period2024 - Q3ReportedManaged Assets$289.961MTotal holdings142
Assets growth rate5.92%Assets growth rate (2-Q avg)1.78%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Highvista Strategies Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 142 positions.
Assets under management
The assets under management (AUM) of Highvista Strategies Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 289.961M in assets, with a quarterly growth rate of 5.92% and a 2-quarter average growth rate of 1.78%. The portfolio is managed by Nicholas Boston, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ETRNEquitrans Midstream Corp
| 0% | $4.024M 310,000 shares@ $12.98 avg price | Exited |
CERECerevel Therapeutics Hldng I
| 0% | $3.975M 97,200 shares@ $40.89 avg price | Exited |
METAMeta Platforms Inc
| 0% | $2.062M 4,090 shares@ $504.23 avg price | Exited |
EQREquity Residential
| 0% | $1.796M 25,900 shares@ $69.34 avg price | Exited |
PFEPfizer Inc
| 0% | $1.687M 60,300 shares@ $27.98 avg price | Exited |
WCCWesco Intl Inc
| 0% | $1.553M 9,797 shares@ $158.52 avg price | Exited |
DUOLDuolingo Inc
| 0% | $1.544M 7,400 shares@ $208.67 avg price | Exited |
WMTWalmart Inc
| 0% | $1.523M 22,500 shares@ $67.71 avg price | Exited |
NVDANvidia Corporation
| 0% | $1.482M 12,000 shares@ $123.54 avg price | Exited |
IDYAIdeaya Biosciences Inc
| 0% | $1.434M 40,856 shares@ $35.11 avg price | Exited |